Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | viral clearance | |||
progesterone | - | 1.31 [1.00; 1.71], 1 RCT, I2=0% unassessable degree of certainty | - | - | ||
5-alpha-reductase inhibitors | 0 | - | - | - | - | |
dutasteride | 0 | - | - | - | - | |
proxalutamide | 0 | - | - | - | - |